The change to a 1+1 pneumococcal vaccine schedule in England highlights rising inequalities in booster uptake, threatening protection for at-risk children.

The RM1bil cost savings that Malaysia stands to gain by switching to generic drugs could be erased by price hikes of up to 50 ...

Health Secretary Robert F. Kennedy Jr.’s vaccine skepticism is posing challenges for the Trump administration. Top health jobs are unfilled, and a court has blocked his vaccine schedule changes. By ...

It's an anniversary no one wants to celebrate, but an anniversary nonetheless. Thursday, March 19, marked six years since the first COVID-19 lockdown was implemented in the United States. And while it ...

Dr. Robert Malone, vice chair of the committee, was appointed by Robert F. Kennedy Jr. after a purge of the previous advisers. By Apoorva Mandavilli Dr. Robert Malone, vice chair of the federal ...

Matthew Herper covers medical innovation — both its promise and its perils. An experimental vaccine from Pfizer and Valneva reduced the risk of developing Lyme disease by more than 70%, according to ...

A Lyme disease vaccine produced by Pfizer and Valneva was deemed 70 percent effective by the companies after they reviewed the results from a phase 3 trial. If approved by regulators, it would be the ...

ORLANDO, Fla. — The Florida Department of Health held its first public workshop Friday on the subject of changing state rules regarding vaccines. It’s part of an ongoing push led by the state’s ...

Pfizer said it will seek regulatory approval for a Lyme disease vaccine candidate despite failing a late-stage trial. Pfizer said not enough people contracted Lyme disease to be confident in the ...

This first evidence of nirsevimab's effectiveness in China validates its value in a novel geographical and implementation ...

Results from a phase 3 clinical trial of Pfizer’s Lyme disease vaccine candidate found it was more than 70 percent effective at preventing the illness. Participants in Pfizer’s trial received four ...